Author

J. Melchor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:variant calling· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

C. A. Iacobuzio-Donahue· 2 shared A. Hayashi· 1 shared A. Heyde· 1 shared A. L. Kung· 1 shared A. Makohon-Moore· 1 shared A. P. Makohon-Moore· 1 shared A. Penson· 1 shared B. Arnold· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. A. Iacobuzio-Donahue

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

M. D. Kinnaman, S. Zaccaria, A. Makohon-Moore, B. Arnold, M. Levine, G. Gundem, J. E. A. Ossa, D. Glodzik, M. I. R. Sanchez, N. Bouvier, S. Li, E. Stockfisch, M. Dunigan, C. Cobbs, U. Bhanot, , C. A. Iacobuzio-Donahue

This study identifies subclonal copy number alterations in relapsed osteosarcoma, showing MYC gain/amplification in treatment-resistant clones and their emergence before chemotherapy.

bioRxiv · Jan 5, 2023 · PreprintCancer Biology

Evolutionary Origins of Recurrent Pancreatic Cancer

H. Sakamoto, M. Attiyeh, J. Gerold, A. P. Makohon-Moore, A. Hayashi, J. Hong, R. Kappagantula, L. Zhang, J. Melchor, J. Reiter, A. Heyde, C. Bielski, A. Penson, D. Chakravarty, E. O'Reilly, , C. A. Iacobuzio-Donahue

This study identifies genetic features of recurrent pancreatic cancer through sequencing and finds that treatment-induced genetic changes and potential second primary tumors influence recurrence.

bioRxiv · Oct 31, 2019Cancer Biology